Italy· 043153067
NOVOEIGHT*1 flaconcino EV 3.000 Unita' Internazionali + 1 siringa solv 4 ml
A blood coagulation factors product containing turoctocog alfa, registered in Italy by NOVO NORDISK A/S, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Turoctocog alfa is registered in 4 of 19 countries.
Countries holding a registration under ATC B02BD (blood coagulation factors), each read from that country’s own register.
- This record: Italy
- 2 of them publish a price we can compare per daily dose
Turoctocog alfa · ATC B02BD
4 / 19 countries
- Ireland
- Italyprice
- Netherlands
- Norwayprice
The record
At a glance
- Active substance
- Turoctocog Alfa
- Manufacturer
- NOVO NORDISK A/S
- Country
- Italy (IT)
- ATC code
- B02BD
- ATC class
- Blood coagulation factors
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic043153067NOVOEIGHT*1 flaconcino EV 3.000 Unita' Internazionali + 1 siringa solv 4 mlEUR 3218.28
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Turoctocog alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenNovoEight 1000 IE Pulver och vätska till injektionsvätska, lösningNovo Nordisk A/S
- CanadaZONOVATENOVO NORDISK CANADA INC
- CzechiaNOVOEIGHTNovo Nordisk A/S, Bagsvaerd
- SpainNOVOEIGHT 1000 UI UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLENovo Nordisk A/S
- FinlandNovoeightNovo Nordisk A/S
- FranceNOVOEIGHT 1000 UI, poudre et solvant pour solution injectableNOVO NORDISK (DANEMARK)
- United KingdomNovoEight 1,000unit powder and solvent for solution for injection vialsNovo Nordisk Ltd
- IrelandNovoEight 1000 IU powder and solvent for solution for injectionNovo Nordisk A/S
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Novoeight
- Norway · Novoeight
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f9bb6f20-b3fa-4f72-b037-1e97dc4323d1 GET /v1/drugs/f9bb6f20-b3fa-4f72-b037-1e97dc4323d1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 3218.28,
"source": "aifa",
"currency": "EUR",
"strength": "TUROCTOCOG ALFA 3.000UI 4ML 1 UNITA' USO PARENTERALE",
"substance": "Turoctocog Alfa",
"equivalence_group": "JAW",
"transparency_flag": null
}See everything about turoctocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.